AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company markets Feraheme, an iron compound for the treatment of iron deficiency anemia in adult patients, and MuGard Mucoadhesive Oral Wound Rinse, an oral rinse for treating oral mucositis. Feraheme (ferumoxytol) Injection is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD). MuGard is indicated for the management of oral mucositis/stomatitis (that may be caused by radiotherapy and/or chemotherapy) and all types of oral wounds (mouth sores and injuries), including aphthous ulcers/canker sores and traumatic ulcers, such as those caused by oral surgery or ill-fitting dentures or braces. It also operates the maternal health division through its subsidiary, Lumara Health Inc. Lumara Health is a marketer of Makena(R) (hydroxyprogesterone caproate injection), which is indicated to reduce the risk of preterm birth in women.